Skip to content
In deliveryUnited Kingdom

Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial

Published
Published 8 December 2025

Overview

This procurement is for the manufacture and testing of over encapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial

Key details

Country
United Kingdom
Status
In delivery
Procedure
Direct
Published
8 December 2025

Award outcome

Awarded value
£494,448
Award date
8 December 2025
Contract period
5 January 2026 → 5 January 2030
Winner
  • ALMAC CLINICAL SERVICES LIMITED

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    21 January 2026

    View notice ↗
  2. Contract

    8 December 2025

    View notice ↗
  3. Contract

    8 December 2025

    View notice ↗

Contracting authority

  • Belfast Health & Social Care Trust

    Buyer

    Belfast, United Kingdom

    GB-PPON: PLQJ-5727-JCLR

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial — won by ALMAC CLINICAL SERVICES LIMITED — Skim